Webdisclosure.com

Search

UCB (EBR:UCB) UCB Media Room: Transparency Notification

Directive transparence : information réglementée

08/11/2019 20:00
https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6HnxeexaJ-2FmRyUFdnCqTu0He-2BNZ6wDOM3gix-2BvZntnC2zLCTqQSOPdBF4= U1Trr22ZWcd2jSMpm8EOVs-2BNNrDXl0fNez_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5B= wmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABm2= 4hM-2FdHtrh1otG6vKMlT0GZ-2FVk476E8EWgJItRsfjzlbpBh2U6-2BWMyUbKn8X-2F44hCshK= IJyEX8A5dQUdso9GDYoGbh-2BTPpuxuSEU6MOGUeKHY8aZiXomCxuJJlB6ioRFzg-2Fthgfhw2A= a8Bfd1qRSbSIlSMuhDgx2jSudjmc-2BhN8QaedRSmD9eb80beppY0WrKrdL6jo7gUO9UN5k9PVA= YnXL5WVRBeq2Hl3-2F8OZG0YUMrqFAfzNXnevUIZdwiHA-3D ** Transparency notifications BlackRock, Inc. ------------------------------------------------------------ =C2=B7 Notifications referring to situation on 4 and 5 November 2019 =C2=B7 Threshold crossed: 5% =C2=B7 Latest holding: 5.13%=C2=A0 Brussels (Belgium), 8 November 2019 =E2=80=93 20:00 (CET) =E2=80=93 regulat= ed information 1.=C2=A0=C2=A0Summary of the notifications Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB SA/NV announces that it has received 2 transparency noti= fications from BlackRock, Inc. (having its registered office at 55 East 52n= d Street, New York, NY, 10055, U.S.A.), dated 5 and 6 November 2019 respect= ively. In the first notification, BlackRock, Inc., has notified that, following a = disposal of UCB shares with voting rights by its affiliates, its holding of= UCB shares with voting rights has decreased and has crossed downwards the = 5% threshold on 4 November 2019.=C2=A0 On 4 November 2019, BlackRock, Inc. (taking into account the holding of its= affiliates) Inc. owned=C2=A09 677 390 UCB shares with voting rights (versu= s 9 841 224 in its previous notification), representing 4.98% of the total = number of shares issued by the company (194 505 658) (versus 5.06% in its p= revious notification), as well as 225 581 equivalent financial instruments = (versus 481 019 in its previous notification) representing 0.12% of the tot= al number of shares issued by the company (versus 0.25% in its previous not= ification).=C2=A0 In the second notification, BlackRock, Inc., has notified that, following a= n acquisition of UCB shares with voting rights by its affiliates, its holdi= ng of UCB shares with voting rights has increased and has crossed the 5% th= reshold on 5 November 2019.=C2=A0 On 5 November 2019, BlackRock, Inc. (taking into account the holding of its= affiliates) 9 753 879 UCB shares with voting rights, representing 5.01% of= the total number of shares issued by the company, as well as 216 713 equiv= alent financial instruments, representing 0.11% of the total number of shar= es issued by the company. 2.=C2=A0=C2=A0Further information This press release and the detailed transparency notifications are availabl= e on UCB SA/NV=E2=80=99s website via the following link (https://u7061146.c= t.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKEbAnX0= k168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIWS8vHM= 8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZf= LoWbvi8z1TsABm24hM-2FdHtrh1otG6vKMlT0GZ-2FVk476E8EWgJItRsfjzlbpBh2U6-2BWMyU= bKn8X-2F44hCshKIJyEX8A5dQUdso9GDYoGbh-2BTPpuxuSEU6MOGUdmSuqyzp2I1IxY-2FrH-2= FoGHoePfOjw3h3lH-2FIwqz2aATrg62O8Wem9cs6UBTroQ1URklUf-2FVWeuTHTDB5CyYbntH-2= B-2FzwbfHs7jFJ3gIgtsm-2FRAJY8rT4vrcWJ1oFjgj-2F7gqETcHqiFeOyb1hvkxQj56A-3D . An updated overview of the UCB SA/NV large shareholdings will be available = on UCB SA/NV=E2=80=99s website via the following link (https://u7061146.ct.= sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKEbAnX0k1= 68L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIWS8vHM8J= K8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLo= Wbvi8z1TsABm24hM-2FdHtrh1otG6vKMlT0GZ-2FVk476E8EWgJItRsfjzlbpBh2U6-2BWMyUbK= n8X-2F44hCshKIJyEX8A5dQUdso9GDYoGbh-2BTPpuxuSEU6MOGURuNl3ijTV3wkAPv-2Febibl= G6bE4Ojt3YZY59k9mYH50dL8Bg9hLxNxdyTQ5Kw22pOV9FEPAq58pYj-2FlX-2FJ6YnsgpCKzfn= yt6G3RI0t6Q82XwUFtbYlLnn-2FJIS-2FhcwSK1qAx2LxxTZrQgvgbNPYeblUA-3D . Investor Relations Antje Witte Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.6 billion i= n 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news =C2=A0 GenericFile 191108 - Notification de transparence comm de presse Blackrock 2 TD (https:= //u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdG= SImvHQ6HnxeexaJ-2FmRyUFdnCqTu0He-2BNZQRgqyKAEyCe4VK-2F27sgOb6IS4lI-2FWv1dN0= BT7X2NUPM-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwc= PKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABm24hM-2FdHtrh1otG6vKMlT0GZ= -2FVk476E8EWgJItRsfjzlbpBh2U6-2BWMyUbKn8X-2F44hCshKIJyEX8A5dQUdso9GDYoGbh-2= BTPpuxuSEU6MOGURRynF6V2DRb5iH9-2B92uWYX1dG0Di3ScU5DgFZypYAD3RnhxRIepndZ4Tj-= 2FOsSHb3Vkdg7-2FNMjIIMnZiFZpmb8QVFe0-2BJVPPiZYch05ldb7iu9UvpO-2F879DMto4Oew= LXOQOL22hRyjYIM1MUMmtZayg-3D GenericFile 191108 - Transparency notification press release Blackrock 2TD (https://u70= 61146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvH= Q6HnxeexaJ-2FmRyUFdnCqTu0He-2BNZYxi2Jt5-2Bp7dBPYDGv5Koifa9TSINZ6j3Dqsh48FHa= T0-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0= hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABm24hM-2FdHtrh1otG6vKMlT0GZ-2FVk47= 6E8EWgJItRsfjzlbpBh2U6-2BWMyUbKn8X-2F44hCshKIJyEX8A5dQUdso9GDYoGbh-2BTPpuxu= SEU6MOGUe9IdYazCNeoJUVgGV6yGmOcdVIyXrdxMaB5yXswfxW-2FTrOk7ftW8k0QDrC-2BduvG= gdLsVVSXQ8yKOT2D8aeMSDTtD4oDeRp6lGW-2BHHtLwO5Xzra2K8qELDLQtzCpF2-2Bl5OmV-2B= RQDPEtI5ahq-2FBhSx54-3D GenericFile 191108- Transparantieverklaring persbericht BlackRock 2TD (https://u7061146= .ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnx= eexaJ-2FmRyUFdnCqTu0He-2BNZoFLT1Pi2h7ae9-2B26nHiaMcEXWJwd2Rrd2rVMf-2BWyz3Y-= 3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTx= d9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABm24hM-2FdHtrh1otG6vKMlT0GZ-2FVk476E8= EWgJItRsfjzlbpBh2U6-2BWMyUbKn8X-2F44hCshKIJyEX8A5dQUdso9GDYoGbh-2BTPpuxuSEU= 6MOGUSWElPggb74H3zArg-2Fqk82XTu3E7AgHu1EItsvcclphRFlWj0emMjxT5wHFRE1AyrbiqB= 6fiErlav-2FdWlYftQ-2BMkQClFFA04aSu9pVPgW-2FRUWS0qzZPCybRvkNnQ8dquI8YMWThNVS= JZvIpObF5a890-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQ= Bz2p53T0v-2BoEIvbo6vDi8C-2BOyFzyb6obo-2BzKSgNKq4mr77MO7-2BTg2sREmDiH1RRWA2k= GLhlAjE2YE7XqadkVZ0aZlIa-2BnP1QzfZi9D5nicjDtXZXHzQPObpVQT8-2F2uNnS5BXTgJvAv= uQRvuDcO9nwfk-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZT= jzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABm24hM-2FdHtrh1otG6vKMl= T0GZ-2FVk476E8EWgJItRsfjzlbpBh2U6-2BWMyUbKn8X-2F44hCshKIJyEX8A5dQUdso9GDYoG= bh-2BTPpuxuSEU6MOGUQfyjRKvDJphA2Krf3DDWOmgx-2Fsem4Bq3woqTE-2BaQScHeZpBS6w-2= B2OeLXEb5tPFfYPPXdN3n73IuTsbZuuEgEXRcbszUbJJmREPli5xnTcKoc7ySU939SCyOBRcoTQ= QGtCgBByz3t4IJePeVvTTIevg-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

25/11/2019 13:31
15/11/2019 07:01
08/11/2019 20:00
08/11/2019 07:01
08/11/2019 07:01
08/11/2019 07:00
18/10/2019 20:00
18/10/2019 07:00
17/10/2019 07:00
11/10/2019 20:01